G1 Therapeutics’ chemo companion nabs speedy FDA review
Chemotherapy can kill off or contain fast-growing cancer cells, but it comes with well-known side effects that can limit its benefit. G1 Therapeutics aims to change that with its CDK4/6 inhibitor, which just snagged priority review from the FDA.